XML 42 R35.htm IDEA: XBRL DOCUMENT v3.25.3

Shareholders' Equity and Share Based Compensation (Tables)

9 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

Summary of Stock Option Activity

Stock option activity for the nine months ended September 30, 2025 was as follows:

		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)				Aggregate Intrinsic Value
Outstanding at December 31, 2024			6,968,409			$	3.30				6.79			$	90
Granted			450,000			$	0.76				4.55			$	—
Exercised			(431,831	)		$	0.97
Forfeited/expired			(93,834	)		$	3.39
Outstanding at September 30, 2025			6,892,744			$	3.28				5.75			$	9,535
Exercisable at September 30, 2025			4,592,752			$	4.44				5.42			$	4,558

Summary of Restricted Shares Activity

Restricted shares activity for the nine months ended September 30, 2025 was as follows:

		Number of Restricted Stock Grants				Weighted Average Grant Date Fair Value
Outstanding at December 31, 2024			700,860			$	0.86
Granted			2,812,740				0.67
Vested and issued			(306,120	)			0.37
Forfeited			(73,566	)			0.60
Outstanding at September 30, 2025			3,133,914			$	0.68
Exercisable at September 30, 2025			—			$	-

Share buyback program

On September 29, 2025, the Board of Directors authorized a $10 million share repurchase for up to 5,687,000 of the Company’s outstanding common stock. Such purchases may be made on the open market, in private transactions and/or pursuant to purchase plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

As of September 30, 2025, there have been no shares purchased since the authorization of the share buyback program.

Warrants

Warrant activity for the nine months ended September 30, 2025 was as follows:

		Number of Shares Underlying the Warrants				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)
Outstanding at December 31, 2024			18,350,000			$	1.65				3.50
Exercised			(1,895,100	)		$	1.65
Issued			—			$	-				-
Expired			—			$	-				-
Outstanding at September 30, 2025			16,454,900			$	1.65				2.75

Summary of Warrant Activity

Warrant activity for the nine months ended September 30, 2025 was as follows:

		Number of Shares Underlying the Warrants				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)
Outstanding at December 31, 2024			18,350,000			$	1.65				3.50
Exercised			(1,895,100	)		$	1.65
Issued			—			$	-				-
Expired			—			$	-				-
Outstanding at September 30, 2025			16,454,900			$	1.65				2.75

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Subparagraph (c)
-Paragraph 2
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration